MSBase investigators to present three oral and six poster presentations at ECTRIMS 2018
Oral Presentations
Sara Eichau, Hospital Universitario Virgen Macarena, Spain
Familial multiple sclerosis: Comparing demographic and clinical characteristics with sporadic form.
Tim Spelman, MSBase statistician
Comparative effectiveness of switching to natalizumab or fingolimod after relapse on first-line relapsing-remitting multiple sclerosis therapy: propensity score matching analysis from the MSBase registry
Nathaniel Lizak, supervised by Tomas Kalincik, The Royal Melbourne Hospital, Australia
Determinants of disability accumulation in secondary-progressive multiple sclerosis
Poster presentations
Stanley Hum, Montreal Neurological Hospital, Canada
Variability in scoring the Functional System Scores of the Expanded Disability Status Scale at Clinics from Different Countries
Amy Kunchok, supervised by Tomas Kalincik, The Royal Melbourne Hospital, Australia
Clinical and therapeutic predictors of relapse and disability outcomes in Neuromyelitis Optica Spectrum Disorder
Minh Le, supervised by Tomas Kalincik, The Royal Melbourne Hospital, Australia
Disability outcomes in patients with early cerebellar symptoms in multiple sclerosis
Charles Malpas, supervised by Tomas Kalincik, The Royal Melbourne Hospital, Australia
Early Clinical Predictors of Severe MS
Anna He, supervised by Tomas Kalincik, The Royal Melbourne Hospital, Australia
To compare patients’ long-term disability outcomes following high efficacy therapy commenced either early or late in their disease course.
Hanafi Husin, supervised by Tomas Kalincik, The Royal Melbourne Hospital, Australia
Determinants of MS re-activation after discontinuing therapies
Back